Motilal Oswal Reaffirms Their Buy Rating on Prestige Estates Projects Limited (PRESTIGE)
Motilal Oswal analyst Abhishek Lodhiya maintained a Buy rating on Prestige Estates Projects Limited (PRESTIGE – Research Report) on June 26 and set a price target of INR2,000.00. The company's shares closed yesterday at INR1,665.40.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Currently, the analyst consensus on Prestige Estates Projects Limited is a Moderate Buy with an average price target of INR1,825.00, representing a 9.58% upside. In a report released yesterday, Ambit Holdings also maintained a Buy rating on the stock with a INR1,850.00 price target.
The company has a one-year high of INR1,971.00 and a one-year low of INR1,048.30. Currently, Prestige Estates Projects Limited has an average volume of 26.93K.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
44 minutes ago
- Business Insider
Goldman Sachs Keeps Their Hold Rating on Coca-Cola Europacific Partners (CCEP)
Goldman Sachs analyst Bonnie Herzog maintained a Hold rating on Coca-Cola Europacific Partners (CCEP – Research Report) on June 27 and set a price target of $70.00. The company's shares closed last Friday at $91.10. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Herzog covers the Consumer Defensive sector, focusing on stocks such as Monster Beverage, Constellation Brands, and Molson Coors. According to TipRanks, Herzog has an average return of 5.2% and a 58.01% success rate on recommended stocks. Coca-Cola Europacific Partners has an analyst consensus of Moderate Buy, with a price target consensus of $94.34.
Business Insider
an hour ago
- Business Insider
Piper Sandler Remains a Buy on Context Therapeutics (CNTX)
Piper Sandler analyst Biren Amin reiterated a Buy rating on Context Therapeutics (CNTX – Research Report) on June 26 and set a price target of $4.00. The company's shares closed last Friday at $0.66. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Amin is an analyst with an average return of -2.5% and a 40.81% success rate. Amin covers the Healthcare sector, focusing on stocks such as BridgeBio Pharma, Sarepta Therapeutics, and Viking Therapeutics. Currently, the analyst consensus on Context Therapeutics is a Strong Buy with an average price target of $4.67. The company has a one-year high of $2.75 and a one-year low of $0.49. Currently, Context Therapeutics has an average volume of 249K.
Business Insider
an hour ago
- Business Insider
Bank of America Securities Sticks to Their Buy Rating for Equinor ASA (EQNR)
In a report released on June 27, Christopher Kuplent from Bank of America Securities maintained a Buy rating on Equinor ASA (EQNR – Research Report), with a price target of $29.00. The company's shares closed last Friday at $25.11. Don't Miss TipRanks' Half Year Sale Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Kuplent is a 2-star analyst with an average return of 0.1% and a 62.90% success rate. Kuplent covers the Energy sector, focusing on stocks such as Shell, Equinor ASA, and Shell (UK). The word on The Street in general, suggests a Hold analyst consensus rating for Equinor ASA with a $24.29 average price target. The company has a one-year high of $29.03 and a one-year low of $21.41. Currently, Equinor ASA has an average volume of 4.22M.
